Calidi Biotherapeutics, Inc.CLDINYSE
Loading
Year-over-year operating cash flow growth rate
| Period | Value |
|---|---|
| Q3 2025 | 13.16% |
| Q2 2025 | 31.57% |
| Q1 2025 | -31.50% |
| Q4 2024 | -9.64% |
| Q3 2024 | -29.10% |
| Q2 2024 | 0.00% |
| Q1 2024 | 26.13% |
| Q4 2023 | 61.63% |
| Q3 2023 | -161.30% |
| Q2 2023 | -66.50% |
| Q1 2023 | 19.84% |
| Q4 2022 | 54.95% |
| Q3 2022 | -190.98% |
| Q2 2022 | -40.41% |
| Q1 2022 | 23.28% |
| Q4 2021 | -86.79% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |